Effects of tautomycetin on proliferation and fibronectin secretion in vascular smooth muscle cells and glomerular mesangial cells.

[1]  M. Kim,et al.  Mycophenolic Acid Inhibits Platelet‐Derived Growth Factor‐Induced Reactive Oxygen Species and Mitogen‐Activated Protein Kinase Activation in Rat Vascular Smooth Muscle Cells , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  J. Chapman,et al.  Evolution and Pathophysiology of Renal-Transplant Glomerulosclerosis , 2004, Transplantation.

[3]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[4]  T. Morio,et al.  Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Kitamura,et al.  Role of High Glucose–Induced Nuclear Factor– B Activation in Monocyte Chemoattractant Protein-1 Expression by Mesangial Cells , 2001 .

[6]  M. Ubukata,et al.  Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1. , 2001, Biochemical and biophysical research communications.

[7]  B. Berk.  Vascular smooth muscle growth: autocrine growth mechanisms. , 2001, Physiological reviews.

[8]  D. Cohen,et al.  MAPK signaling and the kidney. , 2000, American journal of physiology. Renal physiology.

[9]  N. Carragher,et al.  The Extracellular Matrix Dynamically Regulates Smooth Muscle Cell Responsiveness to PDGF a , 2000, Annals of the New York Academy of Sciences.

[10]  B. McManus,et al.  Emerging roles of endothelial cells and smooth muscle cells in transplant vascular disease , 1999 .

[11]  C. Alpers,et al.  Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. , 1996, The American journal of pathology.

[12]  J. Floege,et al.  Multiple roles for platelet-derived growth factor in renal disease. , 1995, Mineral and electrolyte metabolism.